A

Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS

Watchlist Manager
Akums Drugs and Pharmaceuticals Ltd
NSE:AKUMS
Watchlist
Price: 543.7 INR 1.97% Market Closed
Market Cap: ₹83.2B

P/S

2
Current
13%
More Expensive
vs 3-y average of 1.7

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2
=
Market Cap
₹75.8B
/
Revenue
₹42.6B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
2
=
Market Cap
₹75.8B
/
Revenue
₹42.6B

Valuation Scenarios

Akums Drugs and Pharmaceuticals Ltd is trading above its 3-year average

If P/S returns to its 3-Year Average (1.7), the stock would be worth ₹479.71 (12% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-12%
Maximum Upside
+223%
Average Upside
58%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 2 ₹543.7
0%
3-Year Average 1.7 ₹479.71
-12%
5-Year Average 1.7 ₹479.71
-12%
Industry Average 6.3 ₹1 754.41
+223%
Country Average 2.6 ₹727.34
+34%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
₹75.8B
/
Jan 2026
₹42.6B
=
2
Current
₹75.8B
/
Mar 2026
₹44.9B
=
1.7
Forward
₹75.8B
/
Mar 2027
₹50.2B
=
1.5
Forward
₹75.8B
/
Mar 2028
₹57.9B
=
1.3
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

In line with most companies in India
Percentile
39th
Based on 2 983 companies
39th percentile
2
Low
0 — 1.5
Typical Range
1.5 — 4.6
High
4.6 —
Distribution Statistics
India
Min 0
30th Percentile 1.5
Median 2.6
70th Percentile 4.6
Max 56 363.4

Akums Drugs and Pharmaceuticals Ltd
Glance View

Akums Drugs and Pharmaceuticals Ltd., an unsung hero within India's healthcare sector, crafts its narrative through a robust commitment to pharmaceutical manufacturing. Founded in 2004, this company quietly emerged as a formidable provider of contract drug manufacturing solutions. Instead of marketing its own branded products, Akums positions itself as the silent partner behind many well-known pharmaceutical names, providing vital production services. By offering end-to-end manufacturing, from raw material sourcing to finished product packaging, Akums ensures that pharmaceutical companies can concentrate on their strengths: marketing and distribution. The company thrives on its vast portfolio, which encompasses the manufacture of nearly every form of a pharmaceutical product—be it tablets, capsules, injectables, or topical treatments. Akums drives revenue through partnerships, where it functions as the backbone of production lines for its clients. Utilizing cutting-edge technology and stringent global standards, Akums not only addresses the varied needs of the pharmaceutical industry but also adapts to the ever-evolving demands of healthcare worldwide. This strategic focus on high-quality contract manufacturing fuels its financial success, allowing it to expand facilities and scale operations, while maintaining a discreet presence that underscores its core philosophy: to innovate in service rather than spotlight.

AKUMS Intrinsic Value
479.02 INR
Overvaluation 12%
Intrinsic Value
Price ₹543.7
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett